AIMT

Aimmune Therapeutics, Inc.
AIMT

Overview Fund Activity
Delisted

AIMT was delisted on the 12th of October, 2020.

Back to rankings

74 hedge funds and large institutions have $453M invested in Aimmune Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 36 increasing their positions, 12 reducing their positions, and 8 closing their positions.

Holders
74
Holders Change
–
Holders Change %
0%
% of All Funds
1.98%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.13%
New
9
Increased
36
Reduced
12
Closed
8
Calls
–
Puts
$13K
Net Calls
-$13K
Net Calls Change
-$13K

Top Buyers

1
FCMI
1
Foresite Capital Management III
California
$14M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$17.4M
3
EA
3
Emerald Advisers
Pennsylvania
$6.97M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$22.8M
5
EAM
5
Eagle Asset Management
Florida
$32M

Top Sellers

1
PAMU
1
Pictet Asset Management (UK)
United Kingdom
$0
2
AllianceBernstein
2
AllianceBernstein
Tennessee
$10.4M
3
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
EA
5
Emerald Acquisition
Washington
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
EA
76
Emerald Acquisition
Washington
– -$154K -14,206 Closed
Tudor Investment Corp
77
Tudor Investment Corp
Connecticut
– -$123K -11,400 Closed
PA
78
Perceptive Advisors
New York
– -$70K -6,448 Closed
Teacher Retirement System of Texas
79
Teacher Retirement System of Texas
Texas
– -$29K -2,658 Closed
TRCT
80
Tower Research Capital (TRC)
New York
– -$2K -148 Closed
1 2 3
4